Ignite Creation Date:
2025-12-24 @ 5:17 PM
Ignite Modification Date:
2026-01-26 @ 7:20 PM
Study NCT ID:
NCT02757950
Status:
COMPLETED
Last Update Posted:
2019-10-01
First Post:
2016-04-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diphtheria | View |